EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic performance of prostate specific antigen in prostrate cancer patients in Benin-City, Nigeria

Olanike F Adewolu, Osaro E Osaigbovo

Highland Medical Research Journal · 25.03.2026 · 23 (2) · 24-27

DOI: 10.4314/hmrj.v23i2.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Highland Medical Research Journal, online erschienen am 25.03.2026. Verfasst von Olanike F Adewolu und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate Cancer is the most common cancer in males and a leading cause of morbidity and mortality in males worldwide. The need for a reliable, accurate, highly sensitive and specific marker for detection and diagnosis of Prostate cancer is important. Prostate Specific Antigen assay has been used in the screening, early detection and diagnosis of prostate cancer globally. Therefore, we sought to evaluate the diagnostic performance of Prostate Specific Antigen at cut off values >4ng/ml and >10ng/ml in Prostate cancer patients.

Methods

Data from 151 patients being treated in the Urology unit, Surgery Department of University of Benin Teaching Hospital, from March 2019 to June 2020 was analyzed. 60(39.7%) were Prostate cancer (CaP) patients and 91(60.3%) patients with Benign Prostatic Hyperplasia (BPH). Biochemical assay for Total Prostate Specific Antigen(tPSA) was done using the Enzyme linked immunosorbent assay method. Statistical Analysis was done using IBM SPSS version 26 and the level of significance was established at p4ng/ml and >10ng/ml Results: The highest number (63.3%) of subjects with Prostate cancer was seen in the 60-80years age group. Statistically significant difference was observed between Mean Serum PSA in subjects with CaP, compared to those with BPH (51.89±36.96ng/ml) (6.72±1.48ng/ml) respectively (P=.000) which cuts across all age groups. Receiver Operative Curve Analysis showed that the Area Under Curve (AUC) for tPSA was 0.644. Diagnostic accuracy, Sensitivity, and Specificity was 55.2%, 82.5%, and 11.1% respectively at cut off value of tPSA >4ng/ml and 62.7%, 77.5%, and 48.1% respectively at cut off value of >10ng/ml.

Conclusion

Total Serum PSA at cut off value >10ng/ml had the highest diagnostic accuracy and Specificity in this study, therefore Screening for and diagnosis of prostate cancer with PSA is more specific, accurate and therefore more useful at the cut off value >10ng/ml than at cut off value of >4ng/ml.

Zitieren

APA

Adewolu, O. F., & Osaigbovo, O. E. (2026). Diagnostic performance of prostate specific antigen in prostrate cancer patients in Benin-City, Nigeria. Highland Medical Research Journal, 23(2), 24-27. https://doi.org/10.4314/hmrj.v23i2.5

Vancouver

Adewolu OF, Osaigbovo OE. Diagnostic performance of prostate specific antigen in prostrate cancer patients in Benin-City, Nigeria. Highland Medical Research Journal. 2026;23(2):24-27. doi:10.4314/hmrj.v23i2.5

BibTeX
@article{Adewolu2026,
  author = {Adewolu, Olanike F and Osaigbovo, Osaro E},
  title = {Diagnostic performance of prostate specific antigen in prostrate cancer patients in Benin-City, Nigeria},
  journal = {Highland Medical Research Journal},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {24--27},
  doi = {10.4314/hmrj.v23i2.5}
}
Kostenlos starten →